Fund Holdings — Qiming U.S. Ventures Management, LLC

Total Portfolio Value
$89.70M
Total Bought
$27.46M
Total Sold
$63.89M
Net Transaction
-$36.43M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
JASPER THERAPEUTICS INC(JSPR)0928,964+928,964027,27430.41%+27,274
KORRO BIO INC(KRRO)368,085368,085017,64233,12836.93%+15,485
VENTYX BIOSCIENCES INC686,370412,225-274,1451,6952,2672.53%+572
HILLEVAX INC558,923558,92308,9719,29510.36%+324
TOURMALINE BIO INC641,691741,691+100,00016,79916,98518.94%+185
KEZAR LIFE SCIENCES INC828,711828,71107857470.83%-38
ELEVATION ONCOLOGY INC2,370,1420-2,370,1421,2730—-1,273
JASPER THERAPEUTICS INC(JSPR)8,519,6480-8,519,6486,7220—-6,722
ICOSAVAX INC3,510,2280-3,510,22855,3210—-55,321
Page 1 of 1
Qiming U.S. Ventures Management, LLC — 13F Holdings — Q1 2024 | TickerTrail